InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (19 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
19
T+90 hit rate
100%
T+90 mean return
+18.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Matsuda Masaru, See Remarks. Director active across 2 companies, notably Arcutis Biotherapeutics, Inc.. In total, 32 filings have been recorded. Split: 1 buy · 19 sells. Total volume traded: €1.6m. History available since 4 September 2021. The latest transaction was disclosed on 3 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Matsuda Masaru
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
1,230 shares@ US$26.1168Common StockSEC:0001628280-26-053754:0
7,372 shares@ US$23.26960.0055% mcap20.3% of flowCommon StockSEC:0001798679-26-000002:0
37,000 shares0Common StockSEC:0001628280-26-014326:0
7,983 shares@ US$25.49840.0064% mcap23.7% of flowCommon StockSEC:0001628280-26-005582:0
1,657 shares@ US$30.230.0016% mcap6.0% of flowCommon StockSEC:0001798679-25-000007:0
989 shares@ US$27.95411.6% of flowCommon StockSEC:0001798679-25-000006:0
7,165 shares@ US$24.712310.2% of flowCommon StockSEC:0001798679-25-000004:0
36,130 shares@ US$16.15637.0% of flowCommon StockSEC:0001787306-25-000134:0
6,330 shares@ US$14.32666.5% of flowCommon StockSEC:0001787306-25-000116:0
1,800 shares@ US$13.78141.4% of flowCommon StockSEC:0002065881-25-000011:0
5,030 shares@ US$15.19955.6% of flowCommon StockSEC:0001787306-25-000086:0
34,000 shares0Common StockSEC:0001787306-25-000038:0
8,338 shares@ US$12.708.5% of flowCommon StockSEC:0001787306-25-000017:0
4,000 shares@ US$1.6920.5% of flowCommon StockSEC:0001787306-24-000168:0
Canonical exit: 29 Aug 2024 (T+90)
1,775 shares@ US$9.68471.3% of flowCommon StockSEC:0001787306-24-000159:1
4,875 shares0Common StockSEC:0001787306-24-000159:0
5,015 shares@ US$8.68423.3% of flowCommon StockSEC:0001787306-24-000145:0
5,220 shares@ US$9.01613.6% of flowCommon StockSEC:0001787306-24-000118:0
4,875 shares0Common StockSEC:0001787306-24-000083:0
5,016 shares@ US$8.73783.4% of flowCommon StockSEC:0001787306-24-000069:0
3,760 shares@ US$11.12123.2% of flowCommon StockSEC:0001787306-24-000042:0
74,000 sharesCommon StockSEC:0001787306-24-000018:0
28,000 shares0Common StockSEC:0001787306-24-000008:0
1,850 shares@ US$1.9790.3% of flowCommon StockSEC:0001787306-23-000126:1
4,875 shares0Common StockSEC:0001787306-23-000126:0
25 of 32 declarations
About Matsuda Masaru
Matsuda Masaru is a declarant with 31 filings in total. In the recent filings sampled, there were EUR 6,246 of buys and EUR 1,545,203 of sells between 2021-09-07 and 2026-05-06, with Cession as the modal transaction nature. He is associated with Arcutis Biotherapeutics, Inc., where the role is See Remarks, and with Halozyme Therapeutics, INC., where his role is SVP, General Counsel.
